The Food and Drug Administration of the United States has approved a prescription drug which uses 3D printing technology. This can allow for customization to suit patients' needs.

Aprecia Pharmaceuticals Co. is the company behind the drug, which will be used for the treatment of epilepsy. The drug, Spritam, was approved for oral use using "ZipDose" technology, which delivers premeasured droplets that disintegrate with liquid when consumed orally.

WebBush Securities analyst Tao Levy says 3D printing will allow for making products "to the specifications of an individual patient rather than (take a) one-size-fits-all kind of approach." 


 3D printing is helping medical professionals perform more precise procedures. By modeling different organs or tumorous areas, doctors can practice operations before the real thing.

 Patients have already begun receiving hip transplants that are printed digitally.

 Researchers have created consumable meat products through 3D printing. The production of printing living human tissue, is also on the way.

Cover image: Wikimedia Commons